Network Penetration Testing for Biotech companies in Atlanta (GA)
Network Penetration Testing for Biotech Companies in Atlanta (GA)
Biotech organizations in Atlanta and across Georgia are prime targets for cybercriminals. Intellectual property, clinical trial data, genomic datasets, and proprietary formulas are far more valuable than credit cards—and attackers know it. Common attack methods include phishing, ransomware, malware, password attacks, SQL injection, and exploit of misconfigured cloud or lab networks. According to 2021 data, the average reported cost of a data breach reached $4.24M, and that figure excludes unreported or undisclosed incidents.
For biotech companies operating around Emory, Georgia Tech, the Atlanta BioInnovation District, and broader Georgia life-science clusters, a serious breach can mean loss of IP, regulatory penalties, and disruption of research and lab operations. To reduce that risk, organizations must regularly review, test, and upgrade their cybersecurity controls—not just on paper, but through realistic attack simulations.
Network penetration testing (often called a pentest) is a controlled, ethical hacking exercise where security specialists simulate real-world attacks against your internal and external networks, cloud environments, and in many cases, lab and OT/IoT systems connected to your biotech infrastructure. The goal is to identify vulnerabilities before adversaries do, demonstrate how they can be exploited, and provide clear remediation guidance.
A well-executed network penetration test helps biotech leadership:
Understand real business risk to research programs, lab systems, and patient or clinical data
Validate existing security controls such as firewalls, VPNs, EDR, and access management
Support compliance efforts with frameworks and regulations such as HIPAA, 21 CFR Part 11, and data protection requirements in sponsored research agreements
Demonstrate due diligence to boards, investors, partners, and regulators
Atlanta & Georgia Biotech Penetration Testing Experience
OCD Tech provides network penetration testing and IT security assessments for biotech, pharmaceutical, medical device, and life-science organizations in Atlanta and throughout Georgia. Our team combines practical red-team expertise with a deep understanding of how modern biotech environments actually operate—cloud-based research platforms, ELN/LIMS systems, sequencing pipelines, high-performance computing clusters, and vendor-integrated lab equipment.
We routinely work with:
Biotech startups and scale-ups in the Atlanta metro area
Research organizations collaborating with universities and hospitals
Clinical-stage companies handling sensitive trial, patient, or genomic data
Our approach goes beyond a simple vulnerability scan. We deliver a targeted, realistic security assessment that highlights where an attacker would actually gain a foothold, how far they could move, and what that would mean for your IP, lab operations, and regulated data. Every engagement includes clear, prioritized remediation steps that your internal IT or security teams can act on immediately.
Network Penetration Testing Methodology
OCD Tech follows a structured, repeatable methodology aligned with industry best practices. We tailor the depth and scope to each biotech environment—whether you are primarily on-premise, cloud-native, or a hybrid of corporate IT and specialized lab infrastructure.
Typical phases include:
Passive Reconnaissance – Quiet information gathering about your external footprint, domains, public systems, and potential data leaks without actively touching your environment.
Active Reconnaissance – Scanning and probing exposed services, VPNs, cloud interfaces, and remote access points to map attack surfaces.
Social Engineering (where in scope) – Testing user resilience against phishing or pretexting, a common entry point for ransomware and IP theft in biotech.
Exploitation – Safely exploiting identified weaknesses (unpatched systems, weak credentials, insecure configurations) to demonstrate real impact.
Post-Exploitation – Assessing what an attacker can do after initial access—such as reaching LIMS/ELN systems, shared research data, or sensitive file shares.
Privilege Escalation – Attempting to gain higher-level access (e.g., domain admin, key service accounts) to evaluate worst-case scenarios.
Lateral Movement – Testing whether an intruder can move from a compromised workstation or lab device into critical biotech systems or production environments.
Maintain Access – Demonstrating how persistent access could be maintained if controls are not properly monitored and hardened.
Covering Tracks – Evaluating logging and monitoring effectiveness by simulating how attackers try to evade detection.
Reporting & Executive Debrief – Delivering a concise executive summary, detailed technical findings, risk ratings, and actionable remediation guidance prioritized by business impact.
This methodology supports not only traditional penetration tests but also more advanced red-team style exercises and assumed compromise scenarios for mature biotech organizations that want to validate their blue-team detection and response capabilities.
National Reach
While we maintain a strong presence in the Atlanta and Georgia biotech ecosystem, OCD Tech also provides network penetration testing services across the U.S., including:
For biotech organizations collaborating across multiple sites or states, this allows for consistent, coordinated security assessments across your entire footprint.
Contact Our Atlanta Network Penetration Testing Consultants
OCD Tech provides network penetration testing, ethical hacking, and cybersecurity consulting to biotech and life-science organizations in Atlanta and throughout Georgia. If you would like to discuss how a targeted penetration test can protect your IP, research data, and lab operations, complete the form below and a team member will contact you shortly.
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)